Clinical Trials Browser

Waldenstrom Macroglobulinemia × loncastuximab tesirine × 90 days × Clear all

NCT05190705 2026-05-20

Loncastuximab Tesirine in WM

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia